| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhu,Fu-Quan | Chairman | 0.49% | |
| Fang,Guang-Yu | Director | 24.12% | BAO XIN INTERNATIONAL INVESTMENT CO., LTD. |
| Zhang,Chuan-Wang | Director | 24.12% | BAO XIN INTERNATIONAL INVESTMENT CO., LTD. |
| Liu,Shui-En | Independent Director | 0.00% | |
| Zhan,Xin-Yi | Independent Director | 0.00% | |
| Wen,Miao-Xin | Independent Director | 0.00% | |
| Shao,Jian-Hua | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 34,465,909 | 146,383,720 | 121,640,976 |
| Operating cost | 27,050,125 | 117,551,890 | 98,042,051 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 7,415,784 | 28,831,830 | 23,598,925 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 7,415,784 | 28,831,830 | 23,598,925 |
| Operating expenses | 5,894,761 | 23,588,220 | 18,393,419 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 1,521,023 | 5,243,610 | 5,205,506 |
| Non-operating income and expenses | 938,995 | 2,389,569 | 1,710,189 |
| Net profit (loss) before tax | 2,460,018 | 7,633,179 | 6,915,695 |
| Income tax expense (benefits) | 583,611 | 1,609,821 | 1,594,621 |
| Net profit (loss) of ongoing business for the current period | 1,876,407 | 6,023,358 | 5,321,074 |
| Profit (loss) of closed units | 0 | 108,423 | 82,308 |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 1,876,407 | 6,131,781 | 5,403,382 |
| Other comprehensive profit (loss), net | 1,411,340 | 597,641 | 447,455 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 3,287,747 | 6,729,422 | 5,850,837 |
| Net profit (loss) attributable to owners of parent company | 827,343 | 2,739,775 | 2,260,964 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 1,049,064 | 3,392,006 | 3,142,418 |
| Comprehensive profit (loss) attributable to owners of parent company | 1,337,613 | 3,150,505 | 2,053,929 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 1,950,134 | 3,578,917 | 3,796,908 |
| Basic earnings per share (yuan) | 6 | 20 | 19 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 529,643 | 14,101,758 | 7,374,536 |
| Net cash inflows (outflows) from investing activities | -685,593 | -7,062,863 | -4,858,837 |
| Net cash inflow (outflow) from financing activities | -4,519,170 | -3,803,540 | -4,430,434 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 494,292 | 595,653 | 12,433 |
| Increase (decrease) in cash and cash equivalents in the current period | -4,180,828 | 3,831,008 | -1,902,302 |
| Beginning balance of cash and cash equivalents | 27,891,962 | 24,060,954 | 25,963,256 |
| Ending balance of cash and cash equivalents | 23,711,134 | 27,891,962 | 24,060,954 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 96,380,802 | 96,966,298 | 87,394,157 |
| Non-current asset | 51,751,426 | 50,042,745 | 39,390,310 |
| Total asset | 148,132,228 | 147,009,043 | 126,784,467 |
| Current liability | 65,051,283 | 66,430,037 | 61,206,430 |
| Non-current liability | 27,107,453 | 26,313,536 | 15,900,079 |
| Total liability | 92,158,736 | 92,743,573 | 77,106,509 |
| share capital | 1,375,397 | 1,375,372 | 1,319,999 |
| Equity - secruity token | - | - | - |
| capital reserve | 15,707,558 | 15,663,929 | 14,940,752 |
| retained earning | 6,987,842 | 7,838,773 | 6,679,880 |
| Other equity | -96,830 | -607,389 | -1,039,929 |
| Treasury stock | - | - | 0 |
| Total equity attributable to owners of parent company | 23,973,967 | 24,270,685 | 21,900,702 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 31,999,525 | 29,994,785 | 27,777,256 |
| Total Equity | 55,973,492 | 54,265,470 | 49,677,958 |
| Share capital awaiting retirement (unit: share) | - | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 174 | 176 | 165 |
| 標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
|---|---|---|---|---|
| 健康資訊管理系統_主系統乙套 | 國立清華大學 | 102/06/19 | 800000.0 | 是 |
